CymitQuimica logo

CAS 160335-89-7

:

Proline,5-hydroxy-N2-(1-oxohexadecyl)ornithylthreonyl-4-hydroxyprolyl-4-[4-hydroxy-3-(sulfooxy)phenyl]threonyl-3-hydroxyglutaminyl-3-hydroxy-4-methyl-,(6®1)-lactam (9CI)

Description:
The chemical substance known as Proline, 5-hydroxy-N2-(1-oxohexadecyl)ornithylthreonyl-4-hydroxyprolyl-4-[4-hydroxy-3-(sulfooxy)phenyl]threonyl-3-hydroxyglutaminyl-3-hydroxy-4-methyl-, (6®1)-lactam, with CAS number 160335-89-7, is a complex organic compound characterized by its intricate structure, which includes multiple amino acid residues and functional groups. This compound features a lactam ring, which is a cyclic amide that can influence its chemical reactivity and stability. The presence of hydroxyl groups and a sulfooxy group suggests potential for hydrogen bonding and increased solubility in polar solvents. The long aliphatic chain (1-oxohexadecyl) may contribute to hydrophobic interactions, affecting its biological activity and membrane permeability. Such compounds are often studied for their potential applications in pharmaceuticals, particularly in drug design and development, due to their ability to mimic natural peptides or proteins. Understanding the specific interactions and properties of this compound requires further investigation into its biological activity and potential therapeutic uses.
Formula:C51H82N8O19S
Synonyms:
  • Proline,5-hydroxy-N2-(1-oxohexadecyl)ornithylthreonyl-4-hydroxyprolyl-4-[4-hydroxy-3-(sulfooxy)phenyl]threonyl-3-hydroxyglutaminyl-3-hydroxy-4-methyl-,cyclic (6® 1)-peptide
  • Wf 11899C
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.
  • FR901382.
    Biosynth
    + Info

    FR901382.

    CAS:

    FR901382, also known as N-[4-[[3-(2-amino-6-methylphenoxy)propyl]amino]-1,8-naphthalimide-2-yl]benzenesulfonamide, is a potent and selective inhibitor of the human calcitonin receptor. It has been shown to inhibit the binding of calcitonin to the receptor and to block the stimulatory effect of calcitonin on osteoclasts. FR901382 is a ligand that binds to the calcitonin receptor. It activates this receptor by blocking its interaction with other proteins such as calcitonin or calcium ions. FR901382 is currently being researched as a potential treatment for osteoporosis and bone cancer.

    Purity:Min. 95%

    Ref: 3D-FF157070

    ne
    To inquire